British Journal of Haematology · 1999 · 153 citations · 11 references
Life SciencesCell BiologyOncologyApoptosisCancer ImmunologyMolecular OncologyApoptosis In CancerApoptosis ModulationBcl-2 Family ProteinsCytokine BiologyMultiple MyelomaAnti-apoptotic ProteinsBcl-2 Protein ExpressionBcl-xl FunctionGrowth Factor Deprivation-induced ApoptosisMcl-1 FunctionMyeloma Cell LinesMyeloma PathogenesisPro-apoptotic Proteins
Multiple myeloma (MM) is a slowly proliferative malignancy in which malignant plasma cells accumulate within the bone marrow. The expression of several anti-apoptotic proteins was evaluated by immunoblotting in human myeloma cell lines and in highly purified native myeloma cells. Expression of Bcl-xL, Mcl-1 and Bcl-2 was found in most of the samples; expression of Bcl-xL and Mcl-1 seemed to be related on myeloma cells. In a system of apoptosis by growth factor deprivation on myeloma cells, we showed that the effect of Bcl-2 seemed minimal whereas Mcl-1 and Bcl-xL were tightly regulated by interleukin (IL)-6. These findings underline the important role of Mcl-1 and Bcl-xL instead of Bcl-2 in IL-6-induced survival of myeloma cells.
11
Stanisław Krajewski, Sharon Bodrug, Maryla Krajewska et al. · PubMed · 1995 · 317 citations
BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
Yiping Tu, Steven Renner, Fei Xu et al. · Dialnet (Universidad de la Rioja) · 1998 · 225 citations
Medicine, Hematology, Oncology +14
Tao Yang, Heather L. Buchan, Karen J. Townsend et al. · Journal of Cellular Physiology · 1996 · 166 citations